The role of interferon gamma in novel coronavirus infection pathogenesis and the possibilities of immune response correction
- Авторлар: Vakhlevsky V.V.1, Tyrenko V.V.1, Bologov S.G.1, Kryukov E.V.1, Toporkov M.M.1
-
Мекемелер:
- S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russia
- Шығарылым: Том 7, № 10 (2021)
- Беттер: 69-77
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288688
- DOI: https://doi.org/10.18565/therapy.2021.10.69-77
- ID: 288688
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Vitaly Vakhlevsky
S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russiaadjunct of the Department of faculty therapy
Vadim Tyrenko
S.M. Kirov Military Medical Academy of the Ministry of Defense of the RussiaMD, professor, head of the Department of faculty therapy
Sergei Bologov
S.M. Kirov Military Medical Academy of the Ministry of Defense of the RussiaMD, professor of the Department of faculty therapy
Evgeny Kryukov
S.M. Kirov Military Medical Academy of the Ministry of Defense of the RussiaMD, professor, head
Mikhail Toporkov
S.M. Kirov Military Medical Academy of the Ministry of Defense of the RussiaPhD, senior lecturer of the Department of faculty therapy
Әдебиет тізімі
- Лобзин Ю.В., Белозеров Е.С., Беляева Т.В., Вожанин В.М. Вирусные болезни человека. С-Пб: СпецЛит. 2015; 400 с. [Lobzin Yu.V., Belozerov E.S., Belyaeva T.V., Vozhanin V.M. Human viral diseases. Saint Petersburg: Spetslit. 2015; 400 pp. (In Russ.)]. ISBN: 978-5-299-00641-4.
- Tyrrell D.A., Bynoe M.L. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966; 1(7428): 76-77. doi: 10.1016/ s0140-6736(66)92364-6.
- Хаитов Р.М. Иммунология: структура и функции иммунной системы. Учебное пособие. М.: ГЭОТАР-Медиа. 2013; 280 с. [Khaitov R.M. Immunology: structure and function of the immune system. Textbook. Moscow; GEOTAR-Media. 2013; 280 pp. (In Russ.)]. ISBN: 978-5-9704-2644-9.
- Xu Z., Shi L., Wang Y. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4): 420-22. doi: 10.1016/S2213-2600I20I30076-X.
- Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5.
- Zhao Y., Qin L., Zhang P. et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020; 5(13): e139834. doi: 10.1172/jci.insight.139834.
- Nara N., Nakayama Y., Okamoto S. et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J. Biol Chem. 2007; 282(42): 30794-803. doi: 10.1074/jbc.M700412200.
- Huber J., Kiefer F.W., Zeyda M. et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J. Clin Endocrinol Metab. 2008; 93(8): 3215-21. doi: 10.1210/jc.2007-2630.
- Duffaut C., Zakaroff-Girard A., Bourlier V. et al. Interplay between human adipocytes and T. lymphocytes in obesity: CCL20 as an adipochemokine and T. lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol. 2009; 29(10): 1608-14. doi: 10.1161/ ATVBAHA.109.192583.
- Hansson G. K., Libby P., Tabas I. Inflammation and plaque vulnerability. J. Intern Med. 2015; 278(5): 483-93. doi: 10.1111/joim.12406.
- Kirii H., Niwa T., Yamada Y. et al. Lack of Interleukin-1B decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003; 23(4): 656-60. doi: 10.1161/01.ATV.0000064374.15232.C3.
- Bermudez E.A., Rifai N., Buring J. et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002; 22(10): 1668-73. doi: 10.1161/01.atv.0000029781.31325.66.
- Козлов В.К. Цитокинотерапия: патогенетическая направленность и клиническая эффективность при инфекционных заболеваниях. Руководство для врачей. СПб: Альтер Эго. 2010; 148 с. [Kozlov V.K. Cytokine therapy: pathogenetic focus and clinical efficacy in infectious diseases. A guide for physicians. Saint Petersburg: Alter Ego. 2010; 148 pp. (In Russ.)]. ISBN: 978-5-91573-022-8.
- Vabret N., Britton G.J., Gruber C. et al.; Sinai Immunology Review Project. Immunology of COVID-19: Current state of the science. Immunity. 2020; 52(6): 910-41. doi: 10.1016/j.immuni.2020.05.002.
- Tan L., Wang Q., Zhang D. et al. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. Signal Transduct Target Ther. 2020; 5(1): 33. doi: 10.1038/s41392-020-0148-4.
- Мясников А.Л., Бернс С.А., Талызин П.А., Ершов Ф.И. Интерферон гамма в терапии пациентов с COVID-19 среднетяжелого течения. Вопросы вирусологии. 2021; 1: 47-54. [Myasnikov A.L., Berns S.A., Talyzin P.A., Ershov F.I. Interferon gamma in the treatment of patients with moderate COVID-19. Voprosy virusologii = Issues of Virology. 2021; 1: 47-54 (In Russ.)]. https://doi.org/10.36233/0507-4088-24.
Қосымша файлдар
![](/img/style/loading.gif)